...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
Reply New Message
Back To Forum List View
Resverlogix Invites Collaborations for use of Apabetalone in Trials and Studies to Combat the Spread of COVID-19 Based on New Research
1
fuzzyjr
Mar 23, 2020 07:34AM
Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
1
fuzzyjr
Mar 23, 2020 07:43AM
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
2
KOO-KOO2
Mar 23, 2020 08:57AM
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
2
cityslicker99
Mar 23, 2020 09:42AM
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
3
Telepanel
Mar 23, 2020 09:44AM
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
2
Cabel
Mar 23, 2020 09:52AM
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
2
Telepanel
Mar 23, 2020 09:54AM
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
4
paladin
Mar 23, 2020 10:26AM
Icon president Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
4
tada
Mar 23, 2020 02:28PM
Icon president Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
2
tada
Mar 23, 2020 05:48PM
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
5
KOO-KOO2
Mar 23, 2020 06:11PM
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
2
KOO-KOO2
Mar 23, 2020 06:34PM

Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....

posted on Mar 23, 2020 07:20PM
Log in to use the IP Check tool [?]

Thanks Jonzo!
Hadn't seen that one before.
Here back at you

re: rvx-297

 http://molpharm.aspetjournals.org/content/92/6/694

 

" RVX-297 suppressed EAE pathology when administered to mice either prophylactically or therapeutically. In addition, the production of multiple cytokines in vivo (Fig. 7) and ex vivo (Table 6) was suppressed by RVX-297. In vivo efficacy was comparable or superior to that of the S1P1 agonist FTY720 (fingolimod), an approved therapeutic agent for the treatment of MS."

4 Recommendations
Icon president Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
5
golfyeti
Mar 23, 2020 07:26PM
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
1
KOO-KOO2
Mar 23, 2020 08:12PM
Icon president Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
9
BearDownAZ
Mar 23, 2020 08:47PM
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
1
KOO-KOO2
Mar 23, 2020 09:05PM
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
1
KOO-KOO2
Mar 23, 2020 09:31PM
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
1
KOO-KOO2
Mar 23, 2020 09:57PM
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
4
fuzzyjr
Mar 24, 2020 09:33AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply